CannBioRx Historical Income Statement
| ATNFW Stock | USD 0.01 0 22.64% |
Historical analysis of CannBioRx Life income statement accounts such as Selling General Administrative of 7.6 M, Interest Income of 0.0 or Other Operating Expenses of 18.7 M can show how well CannBioRx Life Sciences performed in making a profits. Evaluating CannBioRx Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CannBioRx Life's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining CannBioRx Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CannBioRx Life Sciences is a good buy for the upcoming year.
CannBioRx |
About CannBioRx Income Statement Analysis
CannBioRx Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CannBioRx Life shareholders. The income statement also shows CannBioRx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
CannBioRx Life Income Statement Chart
Add Fundamental
Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of CannBioRx Life Sciences. It is also known as CannBioRx Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from CannBioRx Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CannBioRx Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CannBioRx Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. At this time, CannBioRx Life's Other Operating Expenses is fairly stable compared to the past year. Total Operating Expenses is likely to climb to about 18.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 7.6 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Research Development | 3.9M | 2.4M | 2.8M | 2.7M | Depreciation And Amortization | 116.3K | 109.0K | 105.7K | 101.1K |
CannBioRx Life income statement Correlations
Click cells to compare fundamentals
CannBioRx Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CannBioRx Life income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 185.1K | 1.1M | 186.2K | 26.7K | 44.83 | 42.59 | |
| Selling General Administrative | 5.9M | 3.4M | 11.7M | 15.5M | 10.7M | 7.6M | |
| Operating Income | (20.9M) | (5.6M) | (15.6M) | (17.9M) | (13.5M) | (14.2M) | |
| Income Before Tax | (25.4M) | (10.9M) | (20.3M) | (39.7M) | (22.3M) | (23.4M) | |
| Net Income | (25.4M) | (10.9M) | (20.3M) | (38.7M) | (19.9M) | (20.9M) | |
| Tax Provision | 257.3K | (20.4K) | (23.2K) | (942.7K) | (3.3M) | (3.1M) | |
| Other Operating Expenses | 25.2M | 5.6M | 20.2M | 39.6M | 13.5M | 18.7M | |
| Ebit | (20.9M) | (9.8M) | (20.2M) | (17.9M) | (22.2M) | (23.4M) | |
| Ebitda | (20.8M) | (9.7M) | (20.0M) | (17.8M) | (22.1M) | (23.2M) | |
| Total Operating Expenses | 25.2M | 5.6M | 20.2M | 39.6M | 13.5M | 18.7M | |
| Total Other Income Expense Net | (4.5M) | (5.3M) | (4.7M) | (21.8M) | (8.8M) | (9.2M) | |
| Income Tax Expense | 9.5K | (20.4K) | 23.2K | 942.7K | (2.3M) | (2.2M) | |
| Depreciation And Amortization | 72.2K | 125.3K | 116.3K | 109.0K | 105.7K | 101.1K | |
| Research Development | 2.0M | 2.3M | 3.9M | 2.4M | 2.8M | 2.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.